Leap therapeutics to present at b. riley securities oncology investor conference

Cambridge, mass., jan. 24, 2022 /prnewswire/ -- leap therapeutics, inc. (nasdaq:lptx), a biotechnology company focused on developing targeted and immuno-oncology therapeutics, today announced that douglas e.

LPTX Ratings Summary

LPTX Quant Ranking